Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 06-2023 | 03-2023 | 12-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,500 | 184,328 | 291,748 | 402,351 | 119,054 |
| Marketable Securities | 524,256 | 487,445 | 499,732 | 504,823 | 607,772 |
| Receivables | 42,655 | 86,184 | 78,059 | 112,354 | 135,251 |
| Inventories | 62,068 | 71,729 | 35,275 | 24,253 | 23,428 |
| Other current assets | 0 | 33,188 | 44,761 | 0 | 63,304 |
| TOTAL | $814,022 | $862,874 | $949,576 | $1,089,041 | $948,810 |
| Non-Current Assets | |||||
| PPE Net | 14,991 | 47,552 | 49,372 | 50,988 | 50,083 |
| Investments And Advances | 3,552 | 4,074 | 2,860 | 5,352 | 39,420 |
| Intangibles | 1,186,406 | 1,220,031 | 1,219,458 | 1,242,823 | 1,273,792 |
| Other Non-Current Assets | 7,341 | 7,972 | 8,245 | 8,728 | 196,413 |
| TOTAL | $1,212,290 | $1,279,628 | $1,279,934 | $1,307,891 | $1,559,707 |
| Total Assets | $2,026,311 | $2,142,502 | $2,229,510 | $2,396,932 | $2,508,517 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,422 | 1,640 | 1,637 | 2,031 | 2,031 |
| Accounts payable and accrued liabilities | 28,388 | 119,819 | 149,225 | 38,579 | N/A |
| Accrued Expenses | 81,417 | N/A | N/A | 118,691 | N/A |
| Other current liabilities | 116,555 | 111,991 | 102,952 | 104,685 | 115,524 |
| TOTAL | $264,311 | $241,701 | $263,897 | $278,346 | $317,916 |
| Non-Current Liabilities | |||||
| Long Term Debt | 613,085 | 239,522 | 237,748 | 291,647 | 286,305 |
| Deferred Revenues | 19,444 | N/A | N/A | 0 | 35,540 |
| Other Non-Current Liabilities | 1,084,520 | 1,586,803 | 1,587,146 | 1,624,803 | 1,872,307 |
| TOTAL | $1,712,951 | $1,869,132 | $1,868,586 | $1,961,177 | $2,218,060 |
| Total Liabilities | $1,977,262 | $2,110,833 | $2,132,483 | $2,239,523 | $2,535,976 |
| Shareholders' Equity | |||||
| Common Shares | 37,655 | 34,232 | 34,232 | 34,232 | 34,232 |
| Retained earnings | -1,013,134 | -941,806 | -867,839 | -823,407 | -1,029,991 |
| Other shareholders' equity | 88,435 | 99,374 | 98,541 | 115,327 | 137,396 |
| TOTAL | $49,049 | $31,669 | $97,027 | $157,410 | $-27,459 |
| Total Liabilities And Equity | $2,026,311 | $2,142,502 | $2,229,510 | $2,396,932 | $2,508,517 |